July 9, 2014
ARLINGTON, Va. — HDMA President and CEO John M. Gray issued the following statement on the release of the 2014 National Drug Control Strategy by the White House Office of National Drug Control Policy (ONDCP).
“We commend the ONDCP for taking a balanced, comprehensive approach to reducing the nation’s prescription drug abuse problem through its 2014 National Drug Control Strategy. Like ONDCP, HDMA believes that the solution to this issue requires a multifaceted strategy, one in which law enforcement is still vital, but combined with adequate monitoring, treatment and education efforts to reduce addiction.
“HDMA and its members are committed to ensuring a safe, secure supply chain for patients in need, while working with industry, federal and state regulatory partners to keep prescription painkillers out of the hands of individuals who will abuse them. Together, we can make meaningful progress in reducing this challenging public health issue.”
HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.